Najdat Bazarbashi نجدت بازارباشي

🫀Valvular cardiogenic shock is probably one of the most underrecognized phenotypes of shock in modern cardiac critical care. What makes this paper particularly important is that it reframes severe valve disease: not as chronic structural cardiology, but as acute hemodynamic catastrophe. The physiology is brutal. Unlike classic ischemic CS, VCS often combines: 🫀 abrupt preload overload 🫀 severe afterload mismatch 🫀 elevated filling pressures 🫀 pulmonary edema 🫀 impaired forward flow 🫀 rapidly collapsing ventriculo arterial coupling And unlike MI related shock: 📌 many of these patients still have relatively preserved LVEF. Which means: normal or “acceptable” EF does NOT exclude severe shock physiology. One of the most fascinating findings: 📌 the aortic valve was the most commonly involved valve. Especially: • aortic stenosis • acute aortic regurgitation And outcomes differed substantially by lesion type. Patients with: ⚠️ stenotic lesions had the worst survival ⚠️ regurgitant lesions performed better ⚠️ mixed lesions remained intermediate Severe AS in shock creates: • fixed forward flow obstruction • catecholamine inefficiency • coronary hypoperfusion • profound ventriculo arterial uncoupling while acute regurgitant lesions may still preserve some forward stroke volume if rapidly corrected. Another extremely important message: 📌 definitive intervention mattered enormously. Compared to medical therapy alone: • surgery had the best survival • percutaneous therapies were intermediate • medical management had the worst outcomes After multivariable adjustment: medical management alone was associated with nearly 4 times higher hazard of death at 1 year. But this study suggests: ⚡ definitive therapy may be the only real survival strategy. The paper also highlights something increasingly relevant for modern CICUs: 📌 prosthetic valve dysfunction accounted for almost one third of VCS cases. With aging populations and expanding TAVR/bioprosthetic use: this phenotype will likely increase dramatically over the next decade. From a hemodynamic perspective, VCS may require: 🩺 earlier invasive monitoring 🩺 advanced echocardiography 🩺 rapid valve team activation 🩺 individualized MCS strategy 🩺 faster transfer to high volume structural centers The study also indirectly supports something many intensivists already suspect: 📌 timing is probably everything. Delayed recognition likely converts salvageable hemodynamic collapse into irreversible multiorgan failure. This is where future research should probably focus: • shock phenotyping by valve lesion • optimal MCS selection • VA coupling analysis • transcatheter rescue timing • CICU to structural heart pathways • predictive models for intervention candidacy 📖 Nair RM, JACC Advances. 2024;3(11):101303. doi.org/10.1016/j.jacadv.202…